The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Tricyclic Triazoles as σEBI
Esteve Pharmaceuticals
Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σEBI
Esteve Pharmaceuticals
Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels and the Norepinephrine Transporter.EBI
Esteve Pharmaceuticals
EST64454: a Highly Soluble σEBI
Esteve Pharmaceuticals
Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σEBI
Esteve Pharmaceuticals
4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σEBI
Esteve Pharmaceuticals
BRD4-kinase inhibitors as cancer therapeuticsBDB
H. Lee Moffitt Cancer Center and Research Institute
1-cyano-pyrrolidine compounds as USP30 inhibitorsBDB
Mission Therapeutics
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related theretoBDB
Arena Pharmaceuticals
Fused pyrimidine derivativesBDB
Hoffmann-La Roche
Ectonucleotidase inhibitors and methods of use thereofBDB
Calithera Biosciences
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.BDB
Institut Pasteur Korea
Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of sameBDB
Bayer Pharma Aktiengesellschaft
Substituted 7-azabicyles and their use as orexin receptor modulatorsBDB
Janssen Pharmaceutica